Damage to surfactant-specific protein in acute respiratory distress syndrome

Lancet

Volumn 353, Issue 9160, 1999, Pages 1232-1237

  Baker, Cathy S ^a   Evans, Timothy W ^b   Randle, Beverley J ^d   Haslam, Patricia L ^a,c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ELASTASE; LUNG SURFACTANT; MONOCLONAL ANTIBODY; SURFACTANT PROTEIN A;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG LAVAGE; MALE; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 0033541596     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)09449-5     Document Type: Article

References (35)

1. Jobe A, Ikegami M. State of the art: surfactant for the treatment of respiratory distress syndrome. Am Rev Respir Dis 1987; 136: 1256-75.
2. Lewis JF, Jobe AH. State of the art: surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 1993; 147: 218-33.
3. Johansson J, Curstedt T, Robertson B. The proteins of the surfactant system. Eur Respir J 1994; 7: 372-91.
4. Tino MJ, Wright JR. Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages. Am J Physiol 1996; 270: L677-88.
5. Kuan S, Rust K, Crouch E. Interactions of surfactant protein D with bacterial lipopolysaccharides: surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage. J Clin Invest 1992; 90: 97-106.
6. Gregory TJ, Steinberg KP, Spragg R, et al. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit CareMed 1997; 155: 1309-15.
7. Anzueto A, Baughman RP, Guntupalli KK, et al. Aerosolised surfactant in adults with sepsis-induced acute respiratory distress syndrome: Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med 1996; 334: 1417-21.
8. Weiland JE, Davis WB, Holter JF, Mohammed JR, Dorinsky PM, Gadek JE. Lung neutrophils in the adult respiratory distress syndrome: clinical and pathological significance. Am Rev Respir Dis 1986; 133: 218-52.
9. Seeger W, Grube C, Gunther A, Schmidt R. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J 1993; 6: 971-77.
10. Ryan SF, Ghassibi Y, Liau DF. Effects of activated polymorphonuclear leukocytes upon pulmonary surfactant in vitro. Am J Respir Cell Mol Biol 1991; 4: 33-41.
11. Pison U, Tam EK, Caughey GH, Hawgood S. Proteolytic inactivation of dog lung surfactant-associated proteins by neutrophil elastase. Biochim Biophys Acta 1989; 992: 251-57.
12. Liau DF, Yin NX, Huang J, Ryan SF. Effects of human polymorphonuclear leukocyte elastase upon surfactant proteins in vitro. Biochim Biophys Acta 1996; 1302: 117-28.
13. Lee CT, Fein AM, Lippmann M, Holzman H, Kimbel P, Weinbaum G. Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome. N Engl J Med 1981; 304: 192-96.
14. McGuire WW, Spragg RG, Cohen AB, Cochrane CG. Studies on the pathogenesis of the adult respiratory distress syndrome. J Clin Invest 1982; 69: 543-53.
15. Suter P, Suter S, Girardin E, Roux-Lombard P, Grau G, Dayer J. High bronchoalveolar lavage levels of tumour necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 1992; 145: 1016-22.
16. Cochrane CG, Spragg RG, Revak SD. Pathogenesis of the adult respiratory distress syndrome. J Clin Invest 1983; 71: 754-61.
17. Yasui S, Nagai A, Aoshiba K, Ozawa Y, Kakuta Y, Konno K. A specific neutrophil elastase inhibitor (ONO-5046.Na) attenuates LPS-induced acute lung inflammation in the hamster. Eur Resp J 1995; 8: 1293-99.
18. Bernard GR, Artigas A, Bringham KL, et al, and The Consensus Committee. Report of the American-European consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. J Crit Care 1994; 9: 72-81.
19. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138: 720-23.
20. Laemmli UK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970; 227: 680-85.
21. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-54.
22. Randle BJ. European patent publication number 0511 011 A1. Paris: European Patent Office, 1992: 1-18.
23. Corbet A, Bedi H, Owens M, Taeusch W. Surfactant protein-A inhibits Ia vage-induced surfactant secretion in newborn rabbits. Am J Med Sci 1992; 304: 246-51.
24. Oosting RS, van Greevenbroek MMJ, Verhoef J, van Golde LMG, Haagsman HP. Structural and functional changes of surfactant protein A induced by ozone. Am J Physiol 1991; 261: L77-83.
25. Karinch AM, Floros J. 5′ splicing and allelic variants of the human pulmonary surfactant protein A genes. Am J Respir Cell Mol Biol 1995; 12: 77-88.
26. Haslam PL, Aggarwal A, Baker CS, Randle BJ, Ratan S, Evans TW. Problems in measurement of surf act ant-specific protein A (SP-A) in broncho alveolar lavage samples showing the need for better standardisation of procedure. Eur Respir J 1997; 10 (suppl 25): 171s(1169).
27. Gregory T, Longmore W, Moxley M, et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991; 88: 1976-81.
28. Robertson B, Kobayashi T, Ganzuka M, Grossman G, Li W, Suzuki Y. Experimental neonatal respiratory failure induced by a monoclonal antibody to the hydrophobic surfactant-associated protein SP-B. PediatrRes 1991; 30: 239-43.
29. Clark JC, Wert SE, Bachurski CJ, Stripp BR, Weaver TE, Whitsett JA. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostatis causing respiratory failure in newborn mice. Proc Natl Acad Sci USA 1995; 92: 7794-98.
30. Nogee LM, Gamier G, Dietz HC, et al. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 1994; 93: 1860-63.
31. LeVine AM, Bruno MD, Huelsman KM, Ross GF, Whitsett JA, Korfhagen TR. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J Immunol 1997; 158: 4336-40.
32. Thiel S, Reid KBM. Structures and functions associated with the group mammalian lectins containing collagen-like sequences. FEBS Lett 1989; 250: 78-84.
33. Torres A, El-Ebiary M, Fabregas N, et al. Value of intra-cellular bacteria detection in the diagnosis of ventilator associated pneumonia. Thorax 1996; 51: 378-84.
34. Haslam PL, Baker CS, Evans TW. Prognostic value of monitoring intra-alveolar levels of neutrophils and surfactant as indicators of survival in acute repistaory distress syndrome. Eur Respir J 1995; 8: 397s.
35. Donnelly SC, MacGregor I, Zamani A, et al. Plasma elastase levels and the development of the adult respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151: 1428-33.